The paper applies Ribo-ITP—isotachophoresis-based RNA concentration with microfluidic size selection—to two sample types inaccessible to conventional ribosome profiling: microdissected CA1 regions of single acute hippocampal slices (12 replicates; estimated few thousand neurons each) and 15 single 16/32-cell mouse embryos. Quality metrics are strong: 28-nt RPF length distributions, start/stop codon enrichment, 77% CDS-frame mapping, and Spearman correlations >0.83 across hippocampal replicates . Pooling yielded >20M genome-mapped and >22M transcriptome-mapped unique molecules, enough for RiboTISH to call 19,475 translons (6,680 novel; including 1,227 upstream, 1,954 downstream, 69 lincRNA) in hippocampus and 2,555 in embryos .
The authors' transcriptome pipeline plus Fourier analysis against RiboBase (~2.35 billion reads, ~1,600 mouse datasets) confirmed periodicity for 251 upstream/28 downstream hippocampal translons and 77/17 embryonic ones; peptidomics added peptide evidence for 47 translons . Functionally, 4 of 7 tested embryonic upstream translons drove GFP in mESCs (including a CTG-initiated Clpx translon), and a pooled CRISPR screen found 4 of 66 translon perturbations reduced growth (p<0.05, FDR<0.25), with clonal Phgdh −/− validation (p=0.00014) . The method's broader utility is already evident—the same group applied Ribo-ITP to microdissected limb buds for forelimb initiation profiling .
Strengths: honest self-assessment (the authors explicitly note modest phenotypes, heterogeneous CRISPR alleles, and abandoned LTP time-course analysis due to microdissection variability), full data/code deposition (GEO GSE300869/GSE300832; GitHub), and dual genome/transcriptome pipelines that partly offset mapping limitations. Caveats BGPT flags: (1) functional validation covers only 7 reporter and 66 screen translons—a tiny fraction of thousands called; (2) downstream translon-CDS correlations are weak and may reflect low expression rather than absent regulation, which the authors acknowledge ; (3) detection is biased toward abundant/high-coverage translons; (4) growth phenotypes are subtle, leaving open whether most translons are functional or translational noise—a live debate in the field . What would change the conclusion: systematic null-ORF control screens showing hit rates at chance, or failure of independent Ribo-ITP datasets to reproduce translon catalogs.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.